Austin Speier
About Austin Speier
Austin Speier is the Chief Strategy Officer with a background in emerging technologies and neurodegeneration research.
Chief Strategy Officer
Austin Speier serves as the Chief Strategy Officer. In this role, he focuses on shaping and directing the company’s strategic initiatives. His responsibilities include steering the overall business strategy, identifying opportunities for growth, and ensuring the alignment of operational activities with long-term goals. His position involves high-level decision-making to improve company performance and market positioning.
Vice President, Emerging Technologies at Precision for Medicine
Before his current role, Austin Speier was the Vice President of Emerging Technologies at Precision for Medicine. In this role, he was instrumental in advising on the design and execution of development and go-to-market strategies for complex or first-in-class products. His work primarily involved collaboration with early-stage and venture-backed clients, addressing key scientific, clinical, regulatory, and reimbursement challenges.
Scientific Research at Brigham & Women’s Hospital
Austin Speier conducted research at the Brigham & Women’s Hospital Center for Neurodegeneration and Disease. His research was focused on Alzheimer’s Disease, contributing to the understanding of this complex neurodegenerative condition. This experience provided him with deep insights into neurological disorders and the scientific methodologies used in disease research.
A.B. in Biology from Harvard College
Austin Speier holds an A.B. cum laude in Biology from Harvard College. During his time at Harvard, he completed the interdisciplinary Honors Neurobiology program, earning a certificate in Mind, Brain, and Behavior Studies. This academic background equipped him with a strong foundation in biological sciences and neurobiology, fostering a multidisciplinary approach to understanding complex biological systems.